Patents by Inventor Asa Elisabeth GLADWIN

Asa Elisabeth GLADWIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUND
    Publication number: 20190389870
    Abstract: The present invention relates to a salt form of a benzodiazepine derivative, in particular crystalline solid state forms, to pharmaceutical compositions comprising the same and to its use in therapy.
    Type: Application
    Filed: September 5, 2019
    Publication date: December 26, 2019
    Inventors: Gossett Augustus CAMPBELL, Asa Elisabeth GLADWIN
  • Pharmaceutical compositions of compound
    Patent number: 10450319
    Abstract: The present invention relates to a salt form of a benzodiazepine derivative, in particular crystalline solid state forms, to pharmaceutical compositions comprising the same and to its use in therapy.
    Type: Grant
    Filed: April 18, 2018
    Date of Patent: October 22, 2019
    Assignee: GlaxoSmithKline Intellectual Property (No.2) Limited
    Inventors: Gossett Augustus Campbell, Asa Elisabeth Gladwin
  • COMPOUND
    Publication number: 20180305365
    Abstract: The present invention relates to a salt form of a benzodiazepine derivative, in particular crystalline solid state forms, to pharmaceutical compositions comprising the same and to its use in therapy.
    Type: Application
    Filed: April 18, 2018
    Publication date: October 25, 2018
    Inventors: Gossett Augustus CAMPBELL, Asa Elisabeth Gladwin
  • Crystalline solid state form of the benzene sulphonic acid salt of 2-[(4S)-6-(4-chlorophenyl)-1-methyl-8-(methyloxy)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide
    Patent number: 9975901
    Abstract: The present invention relates to a salt form of a benzodiazepine derivative, in particular crystalline solid state forms, to pharmaceutical compositions comprising the same and to its use in therapy.
    Type: Grant
    Filed: September 30, 2015
    Date of Patent: May 22, 2018
    Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
    Inventors: Gossett Augustus Campbell, Asa Elisabeth Gladwin
  • COMPOUND
    Publication number: 20170298071
    Abstract: The present invention relates to a salt form of a benzodiazepine derivative, in particular crystalline solid state forms, to pharmaceutical compositions comprising the same and to its use in therapy.
    Type: Application
    Filed: September 30, 2015
    Publication date: October 19, 2017
    Inventors: Gossett Augustus CAMPBELL, Asa Elisabeth GLADWIN